BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 4555967)

  • 1. The continuous bacteremia of lepromatous leprosy.
    Drutz DJ; Chen TS; Lu WH
    N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
    [No Abstract]   [Full Text] [Related]  

  • 2. The histopathology of lepromatous leprosy in the nose.
    McDougall AC; Rees RJ; Weddell AG; Kanan MW
    J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 4. Histoid leprosy: histopathological connotations' relevance in contemporary context.
    Sehgal VN; Srivastava G; Singh N
    Am J Dermatopathol; 2009 May; 31(3):268-71. PubMed ID: 19384068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
    Pearson JM; Pettit JH
    Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of nasal lesions in early lepromatous leprosy.
    Barton RP
    Ann R Coll Surg Engl; 1975 Dec; 57(6):309-12. PubMed ID: 1108744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
    Waters MF; Rees RJ; McDougall AC; Weddell AG
    Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
    [No Abstract]   [Full Text] [Related]  

  • 8. Viability of blood-borne Mycobacterium leprae.
    Drutz DJ; O'Neill SM; Levy L
    J Infect Dis; 1974 Sep; 130(3):288-92. PubMed ID: 4607341
    [No Abstract]   [Full Text] [Related]  

  • 9. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 11. [localization and topographic distribution of Hansen's bacilli at the level of leprotic lesions].
    Le-Kinh-Due ; Nguyen-Nguyen ; Dô-Trong-Lâm
    Dermatol Monatsschr; 1971 Apr; 157(4):225-31. PubMed ID: 4938032
    [No Abstract]   [Full Text] [Related]  

  • 12. Lepromatous leprosy in the nose after one year of dapsone treatment: histopathological findings.
    McDougall AC; Weddell AG; Rees RJ
    Lepr Rev; 1975 Dec; 46(4):267-77. PubMed ID: 1107726
    [No Abstract]   [Full Text] [Related]  

  • 13. Leprosy's footprints in bone-marrow histiocytes.
    Lawrence C; Schreiber AJ
    N Engl J Med; 1979 Apr; 300(15):834-5. PubMed ID: 85259
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of lepromatous leprosy].
    Butov IuS; Lezvinskaia EM; Ponomareva EI
    Vestn Dermatol Venerol; 1988; (3):62-4. PubMed ID: 3289278
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
    Languillon J; Yawalkar SJ; McDougall AC
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 18. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacillaemia in lepra reaction: its correlation with liver pathology.
    Zawar PB; Holla VV; Patil SM; Zawar MP; Chawhan RN
    Lepr India; 1983 Jul; 55(3):570-5. PubMed ID: 6361382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the earlobe in leprosy. A clinical and histopathological study.
    Mansfield RE; Storkan MA; Cliff IS
    Arch Dermatol; 1969 Oct; 100(4):407-12. PubMed ID: 4902083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.